Cargando…
Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review
The first corona-pandemic, coronavirus disease 2019 (COVID-19) caused a huge health crisis and incalculable damage worldwide. Knowledge of how to cure the disease is urgently needed. Emerging immune escaping mutants of the virus suggested that it may be potentially persistent in human society as a r...
Autores principales: | Zhong, Li, Zhu, Lin, Cai, Zong-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423835/ https://www.ncbi.nlm.nih.gov/pubmed/34513131 http://dx.doi.org/10.1007/s41664-021-00197-6 |
Ejemplares similares
-
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014) -
Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
por: Doud, Emma H., et al.
Publicado: (2023) -
Mass Spectrometry-Based Glycoproteomics and Prostate Cancer
por: Gabriele, Caterina, et al.
Publicado: (2021) -
Glycoproteomics-Based Identification of Cancer Biomarkers
por: Kim, Evelyn H., et al.
Publicado: (2011) -
Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry
por: Han, Dohyun, et al.
Publicado: (2014)